Form4insider filings, from the source

Insider holders · CIK 0001867096

Xeris Biopharma Holdings, Inc. · XERS

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
John Patrick Shannon Jr.See Remarks2,898,933—2,898,933Aug 21, 2026 · 4:23 pm EDTForm 4
Kevin McCullochSee Remarks1,639,20825,0001,664,208Sep 1, 2026 · 6:21 pm EDTForm 4
Steven PieperSee Remarks1,356,053—1,356,053Sep 1, 2026 · 6:20 pm EDTForm 4
Beth HechtSee Remarks1,127,796—1,127,796Sep 1, 2026 · 6:21 pm EDTForm 4
John JohnsonDirector707,276—707,276Jun 5, 2026 · 6:17 pm EDTForm 4
Garheng KongDirector238,337—238,337Jun 5, 2026 · 6:39 pm EDTForm 4
Marla PerskyDirector150,6936,370157,063Jun 5, 2026 · 6:29 pm EDTForm 4
Barbara-Jean Anne Bormann-KennedyDirector150,693—150,693Jun 5, 2026 · 6:18 pm EDTForm 4
Dawn HalkuffDirector119,1935,410124,603Jun 5, 2026 · 6:18 pm EDTForm 4
James Aloysius BradyDirector113,359—113,359Jun 5, 2026 · 6:16 pm EDTForm 4
Nerissa KreherDirector33,582—33,582Jul 2, 2026 · 6:01 pm EDTForm 4

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.